Gerard D. Schellenberg

43.3k citations

214 papers · 16.9k indexed · 5 hit papers · h-index 65

Impact in

Physiology top 0.05%
- Alzheimer's disease research and treatments
Aging top 0.2%

Papers in

Physiology 119
- Alzheimer's disease research and treatments 118
Neurology 35
- Parkinson's Disease Mechanisms and Treatments 26

Co-authors: Ellen M. Wijsman Thomas D. Bird Parvoneh Poorkaj Ian D’Souza Ellen Nemens Chang-En Yu Murray A. Raskind Junko Oshima
Journals: Alzheimer s & Dementia (32 papers)Annals of Neurology (14 papers)Genomics (12 papers)Neurobiology of Aging (9 papers)Neurology (8 papers)
Partner nations: United States Japan Canada

In The Last Decade

Gerard D. Schellenberg

211 papers receiving 16.5k citations

Hit Papers

5 papers align trajectories log scale

Dementia and Alzheimer Disease Incidence 2002 · 563 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Archives of Neurology
1998 Annals of Neurology
1996 Science
1995 Science
1992 Science

Peers

Countries citing papers authored by Gerard D. Schellenberg

Since Specialization

Citations

This map shows the geographic impact of Gerard D. Schellenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard D. Schellenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard D. Schellenberg more than expected).

Fields of papers citing papers by Gerard D. Schellenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard D. Schellenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard D. Schellenberg. The network helps show where Gerard D. Schellenberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerard D. Schellenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerard D. Schellenberg Line = papers co-authored together Gerard D. Schellenberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons Acta Neuropathologica ·Hong Xu, Qi Qiu, Peng Hu, Kevt’her Hoxha, Elliot Jang, Mia O’Reilly, Christopher Kim, Zhuohao He, Nicholas P. Marotta, Lakshmi Changolkar, Bin Zhang, Hao Wu, Gerard D. Schellenberg, Brian C. Kraemer, Kelvin C. Luk, Edward B. Lee, John Q. Trojanowski, Kurt R. Brunden, Virginia M.‐Y. Lee	2024	3
2	A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease Alzheimer s & Dementia ·Haimeng Bai, Adam C. Naj, Penelope Benchek, Logan Dumitrescu, Timothy J. Hohman, Kara L. Hamilton‐Nelson, Asha Kallianpur, Anthony J. Griswold, Badri N. Vardarajan, Eden R. Martin, Gary W. Beecham, Jennifer E. Below, Gerard D. Schellenberg, Richard Mayeux, Lindsay A. Farrer, Margaret A. Pericak‐Vance, Jonathan L. Haines, William S. Bush	2023	5
3	The Early‐Onset Alzheimer's Disease Whole‐Genome Sequencing Project: Study design and methodology Alzheimer s & Dementia ·Nicholas R. Ray, Temitope Ayodele, Melissa Jean‐Francois, Penelope Baez, María Victoria Fernández, Joseph Bradley, Paul K. Crane, Clifton L. Dalgard, Amanda B Kuzma, Heather Nicaretta, Rebecca Sims, Julie Williams, Michael L. Cuccaro, Margaret A. Pericak‐Vance, Richard Mayeux, Weixin Wang, Gerard D. Schellenberg, Carlos Cruchaga, Gary W. Beecham, Christiane Reitz	2023	2
4	NIAGADS Alzheimer's GenomicsDB: A resource for exploring Alzheimer's disease genetic and genomic knowledge Alzheimer s & Dementia ·Emily Greenfest‐Allen, Otto Valladares, Pavel P. Kuksa, Prabhakaran Gangadharan, Wan‐Ping Lee, Jeffrey Cifello, Živadin Katanić, Amanda B Kuzma, Nicholas R. Wheeler, William S. Bush, Yuk Yee Leung, Gerard D. Schellenberg, Christian J. Stoeckert, Li‐San Wang	2023	11
5	The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases Frontiers in Aging Neuroscience ·Hui Wang, Li‐San Wang, Gerard D. Schellenberg, Wan‐Ping Lee	2023	12
6	TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy Science Advances ·Carolina Alquézar, Kathleen M. Schoch, Ethan G. Geier, Eliana Marisa Ramos, Aurora Scrivo, Kathy H. Li, Andrea R. Argouarch, Elisabeth E. Mlynarski, Beth A. Dombroski, Michael DeTure, Dennis W. Dickson, Jennifer S. Yokoyama, Ana María Cuervo, Alma L. Burlingame, Gerard D. Schellenberg, Timothy M. Miller, Bruce L. Miller, Aimee W. Kao	2021	26
7	LRP10 variants in progressive supranuclear palsy Neurobiology of Aging ·Leonie J.M. Vergouw, Shamiram Melhem, Laura Donker Kaat, Wang Zheng Chiu, Demy J.S. Kuipers, Guido J. Breedveld, Agnita J.W. Boon, Li-San Wang, Adam C. Naj, Elizabeth Mlynarksi, Laura B. Cantwell, Marialuisa Quadri, Owen A. Ross, Dennis W. Dickson, Gerard D. Schellenberg, John C. van Swieten, Vincenzo Bonifati, Frank Jan de Jong	2020	5
8	VCPA: genomic variant calling pipeline and data management tool for Alzheimer’s Disease Sequencing Project Bioinformatics ·Yuk Yee Leung, Otto Valladares, Yi‐Fan Chou, Han‐Jen Lin, Amanda B Kuzma, Laura B. Cantwell, Liming Qu, Prabhakaran Gangadharan, William Salerno, Gerard D. Schellenberg, Li‐San Wang	2018	20
9	Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease Alzheimer s & Dementia Translational Research & Clinical Interventions ·Ilana Belitskaya‐Lévy, Maurice W. Dysken, Peter Guarino, Mary Sano, Sanjay Asthana, Julia E. Vertrees, Muralidhar Pallaki, Maria D. Llorente, Susan Love, Gerard D. Schellenberg	2018	9
10	[O1–03–01]: GENOME‐WIDE RARE VARIANT IMPUTATION AND TISSUE‐SPECIFIC TRANSCRIPTOMIC ANALYSIS IDENTIFY NOVEL RARE VARIANT CANDIDATE LOCI IN LATE‐ONSET ALZHEIMER's DISEASE: THE ALZHEIMER's DISEASE GENETICS CONSORTIUM Alzheimer s & Dementia ·Adam C. Naj, Jennifer E. Below, Yi Zhao, Hung‐Hsin Chen, Sven J. van der Lee, Kara L. Hamilton‐Nelson, Lauren E. Petty, Brian W. Kunkle, Amanda Kuzma, Otto Valladares, Christiane Reitz, Gary W. Beecham, Eden R. Martin, Weixin Wang, Jonathan L. Haines, Richard Mayeux, Lindsay A. Farrer, Margaret A. Pericak‐Vance, Gerard D. Schellenberg	2017	3
11	Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP) Translational Psychiatry ·Christiane Reitz, Giuseppe Tosto, Badri N. Vardarajan, Ekaterina Rogaeva, Mahdi Ghani, Robert S. Rogers, Christopher Conrad, J.L. Haines, Margaret A. Pericak‐Vance, M. Daniele Fallin, Tatiana Foroud, Lindsay A. Farrer, Gerard D. Schellenberg, Peter St George‐Hyslop, Richard Mayeux	2013	58
12	SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans Human Molecular Genetics ·Chris R. Guthrie, Gerard D. Schellenberg, Brian C. Kraemer	2009	86
13	Preclinical Evidence of Alzheimer Changes Archives of Neurology ·Eric C. Petrie, Donna J. Cross, Douglas Galasko, Gerard D. Schellenberg, Murray A. Raskind, Elaine R. Peskind, Satoshi Minoshima	2009	80
14	A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology Brain ·James B. Leverenz, Chang Yu, Thomas J. Montine, Ellen J. Steinbart, Lynn M. Bekris, Cyrus P. Zabetian, L K Kwong, Virginia M‐Y. Lee, Gerard D. Schellenberg, Thomas D. Bird	2007	96
15	Using Caenorhabditis elegans Models of Neurodegenerative Disease to Identify Neuroprotective Strategies International review of neurobiology ·Brian C. Kraemer, Gerard D. Schellenberg	2006	7
16	Arginine/Serine-rich Protein Interaction Domain-dependent Modulation of a Tau Exon 10 Splicing Enhancer Journal of Biological Chemistry ·Ian D’Souza, Gerard D. Schellenberg	2005	42
17	Developmental and vascular risk factors for Alzheimer's disease Neurobiology of Aging ·Amy R. Borenstein, Yougui Wu, James A. Mortimer, Gerard D. Schellenberg, Wayne C. McCormick, James D. Bowen, Susan M. McCurry, Eric B. Larson	2004	91
18	Using Census Data and Birth Certificates to Reconstruct the Early-Life Socioeconomic Environment and the Relation to the Development of Alzheimer’s Disease Epidemiology ·Victoria M. Moceri, Walter A. Kukull, Irvin Emanual, Gerald van Belle, Jacqueline R. Starr, Gerard D. Schellenberg, Wayne C. McCormick, James D. Bowen, Linda Teri, Eric B. Larson	2001	98
19	Determinants of 4-Repeat Tau Expression Journal of Biological Chemistry ·Ian D’Souza, Gerard D. Schellenberg	2000	116
20	Physical and Functional Interaction between p53 and the Werner's Syndrome Protein Journal of Biological Chemistry ·Gil Blander, Jonathan Kipnis, Juan Fernando Martínez-Leal, Chang-En Yu, Gerard D. Schellenberg, Moshe Oren	1999	147

About Gerard D. Schellenberg

Gerard D. Schellenberg is a scholar working on Physiology, Neurology, Aging, Genetics and Neurology, having authored 214 papers that have together received 16.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (118 papers), Bioinformatics and Genomic Networks (38 papers), Genetic Associations and Epidemiology (31 papers), Parkinson's Disease Mechanisms and Treatments (26 papers), Dementia and Cognitive Impairment Research (26 papers), Nuclear Receptors and Signaling (14 papers), Prion Diseases and Protein Misfolding (14 papers) and Genomics and Rare Diseases (13 papers). The work is most often cited by research in Physiology (9.5k citations), Aging (595 citations), Neurology (2.4k citations), Neurology (3.0k citations) and Biological Psychiatry (436 citations). Gerard D. Schellenberg has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Ellen M. Wijsman, Thomas D. Bird, Parvoneh Poorkaj, Ian D’Souza, Ellen Nemens, Chang-En Yu, Murray A. Raskind, Junko Oshima, Ying‐Hui Fu and George M. Martin. Their work appears in journals such as Alzheimer s & Dementia, Annals of Neurology, Genomics, Neurobiology of Aging and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact